Expert Pitch
University of California, Los Angeles (UCLA), Health Sciences

UCLA Fielding School of Public Health faculty experts available for media covering novel coronavirus (COVID-19)

Newswise — UCLA Fielding School of Public Health experts available for media covering novel coronavirus (COVID-19) include:

Dr. Robert J. Kim-Farley serves as professor-in-residence of epidemiology and community health sciences at the Fielding School. His previous roles include director of the Division of Communicable Disease Control and Prevention at the Los Angeles County Department of Public Health, and service with the U.S. Centers for Disease Control and Prevention, and the World Health Organization in Indonesia, India, and Switzerland. Kim-Farley addresses public health preparedness for, and response to, deliberate use of biological agents, and reduction and eradication of communicable diseases. Recently quoted by The Guardian, Los Angeles Times, and National Public Radio.

Anne Rimoin, a professor of epidemiology at the Fielding School, is an expert in emerging infectious diseases, ebolavirus, zoonoses, immunization, and infectious disease epidemiology. Rimoin is the founder of the UCLA-DRC Health Research and Training Program in the Democratic Republic of the Congo and serves as director of the Center for Global and Immigrant Health at the Fielding School. Recently quoted by the BBC News, Forbes, Fox Business, and USA Today.

Gilbert Gee is a professor of community health sciences at the Fielding School. A primary line of his research focuses on conceptualizing and measuring racial discrimination, and in understanding how discrimination may be related to illness. His work on health surveys and disease exposure has been recognized by the (U.S.) National Institutes of Health and the Environmental Protection Agency. Recently quoted in PBS: Christiane Amanpour & Co., the Los Angeles Times, Fort Worth Star-Telegram, and Seattle Times.

Dr. Zuo-Feng Zhang is the associate dean for research and a professor of epidemiology at the Fielding School. Zhang’s service includes his tenure as WHO Consultant for National Noncommunicable Disease Prevention and Controls in China, and as a regular member of NIH Epidemiology of Cancer Study Section. Recently quoted by Xinhua, China Philanthropist, and The Intellectual.

Dr. Timothy Brewer, professor of epidemiology at the Fielding School, has served on advisory boards and review panels for international and national organizations including the World Health Organization, the National Institutes of Health, the US Centers for Disease Control and Prevention, and the Canadian Institutes of Health Research, among others, and currently serves as the Chair of the Board of Directors for the Consortium of Universities for Global Health. Recently quoted in the New York Times and Los Angeles Times.

Dr. David Eisenman, is director of the Center for Public Health and Disasters and professor-in-residence of community health sciences at the Fielding School. Eisenman’s work addresses community resilience, mental health in primary care, trauma, climate change, and violence prevention.

Dr. Jeffrey Klausner is an adjunct professor of epidemiology at the Fielding School whose research interests are in applied epidemiology and the prevention and control of infectious diseases of public health importance like HIV, STDs, TB and Cryptococcus. Klausner previously served with the San Francisco County Department of Public Health and the U.S. Centers for Disease Control and Prevention. Recently quoted in the Los Angeles Times and Fox News Los Angeles.

On Feb. 10, the Fielding School hosted a symposium on COVID-19 titled "What do we know and what's next?" Speakers included faculty from the UCLA Fielding School of Public Health, the David Geffen School of Medicine at UCLA, the UCLA School of Law, and  the UCLA Center for Chinese Studies. A video of the event is NOVEL CORONAVIRUS: WHAT DO WE KNOW AND WHAT'S NEXT?:




Filters close

Showing results

110 of 2454
Released: 3-Jul-2020 10:25 AM EDT
Lack of lockdown increased COVID-19 deaths in Sweden
University of Virginia Health System

Sweden’s controversial decision not to lock down during COVID-19 produced more deaths and greater healthcare demand than seen in countries with earlier, more stringent interventions, a new analysis finds.

Released: 2-Jul-2020 3:10 PM EDT
Researchers outline adapted health communications principles for the COVID-19 pandemic
CUNY Graduate School of Public Health and Health Policy

The COVID-19 pandemic has introduced unique challenges for public health practitioners and health communicators that warrant an expansion of existing health communication principles to take into consideration.

Released: 2-Jul-2020 1:40 PM EDT
Collectivism drives efforts to reduce the spread of COVID-19
University of Kent

Research from the University of Kent has found that people who adopt a collectivist mindset are more likely to comply with social distancing and hygiene practices to help reduce the spread of COVID-19.

Released: 2-Jul-2020 12:30 PM EDT
Tiny mineral particles are better vehicles for promising gene therapy
University of Wisconsin-Madison

University of Wisconsin–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination — including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans.

Newswise: Newer variant of COVID-19–causing virus dominates global infections
Released: 2-Jul-2020 12:10 PM EDT
Newer variant of COVID-19–causing virus dominates global infections
Los Alamos National Laboratory

Research out today in the journal Cell shows that a specific change in the SARS-CoV-2 coronavirus virus genome, previously associated with increased viral transmission and the spread of COVID-19, is more infectious in cell culture.

Newswise: From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
Released: 2-Jul-2020 12:05 PM EDT
From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
La Jolla Institute for Immunology

Two variants of the novel coronavirus (SARS-CoV-2), called G614 and D614, were circulating in mid-March. A new study shows that the G version of the virus has come to dominate cases around the world. They report that this mutation does not make the virus more deadly, but it does help the virus copy itself, resulting in a higher viral load, or "titer," in patients.

Released: 2-Jul-2020 11:50 AM EDT
New Study Explains Potential Causes for “Happy Hypoxia” Condition in COVID-19 Patients
Loyola Medicine

A new research study provides possible explanations for COVID-19 patients who present with extremely low, otherwise life-threatening levels of oxygen, but no signs of dyspnea (difficulty breathing). This new understanding of the condition, known as silent hypoxemia or “happy hypoxia,” could prevent unnecessary intubation and ventilation in patients during the current and expected second wave of coronavirus.

Released: 2-Jul-2020 10:15 AM EDT
Stemming the Spread of Misinformation on Social Media
Association for Psychological Science

New research reported in the journal Psychological Science finds that priming people to think about accuracy could make them more discerning in what they subsequently share on social media.

29-Jun-2020 9:00 AM EDT
Coronavirus damages the endocrine system
Endocrine Society

People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.


Showing results

110 of 2454

close
0.79869